| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 08/13/2008 | CN101239980A Immunity receptor regulator couplet precursor, couplet and application thereof |
| 08/13/2008 | CN101239186A Use of soluble lymphotoxin-beta receptors |
| 08/13/2008 | CN101239174A Foot plaster and hand plaster |
| 08/13/2008 | CN101239156A Super medicated leaven high polymer renaturation blood circulation activating and stasis removing traditional Chinese medicine preparation series |
| 08/13/2008 | CN101239129A Method for preparing Chinese medicine with qi-benefitting and detoxication, blood seasis-dispersing and detumescence, and stomach-regulating and sedative function |
| 08/13/2008 | CN101239127A Bioactivity spray |
| 08/13/2008 | CN101239078A Placenta immunoregulation medicament capsule |
| 08/13/2008 | CN101239076A Blood plasma immunoregulation medicament capsule |
| 08/13/2008 | CN101239063A Pharmaceutical compositions |
| 08/13/2008 | CN101239048A Cyclosporine A fast release solid dosage forms and preparation thereof |
| 08/13/2008 | CN101238848A Chinese medicine nucleic acid feed additive |
| 08/13/2008 | CN100410250C Spiroheterocyclic compoundsus reversible inhibitors of cysteine proteases |
| 08/13/2008 | CN100410245C Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents |
| 08/13/2008 | CN100409855C Tablet containing lucid ganoderma and spirulina spp., and its preparation method |
| 08/13/2008 | CN100409841C Pharmaceutical or cosmetic composition and use of a pkc inhibitor with an mmp inhibitor for inhibiting langerhans' cell migration |
| 08/12/2008 | US7411072 e.g. 5-(10,11-Dihydro-dibenzo[a,d]cyclohepten-5-ylidenemethyl)-3H-benzooxazol-2-one; antiinflammatory, antidiabetic agent; electrolytes and water retention modulator; hypotensive, hypoglycemic agent; arrhythmias, myocardial fibrosis, osteoporosis, polyuria, polydipsia, Crohn's disease |
| 08/12/2008 | US7411055 Genetic engineering |
| 08/12/2008 | US7411050 Bioassay for detection of receptor activated nuclear factor kappa beta ligand (RANKL); identifying modulator immune and inflammatory response |
| 08/12/2008 | US7411041 DCRS5 polypeptides |
| 08/12/2008 | US7410991 Pyrazolidinone compounds as ligands of the prostaglandin EP2 and/or EP4 receptors |
| 08/12/2008 | US7410986 For therapy of inflammatory symptoms; tumors, ischemia and tumor |
| 08/12/2008 | US7410984 novel pyridone derivatives capable of inhibiting alpha 4 integrin mediated cell adhesion; to treat chronic inflammatory diseases; 3-(4-{2-Oxo-3-[4-(3-o-tolyl-ureido)phenyl]-2H-pyridin-1-ylmethyl}phenyl)propionic acid; hydrolysis |
| 08/12/2008 | US7410971 1,2-di(cyclic)substituted benzene compounds |
| 08/12/2008 | US7410966 Use of and some novel imidazopyridines |
| 08/12/2008 | US7410956 Caspase inhibitor prodrugs |
| 08/12/2008 | US7410955 Therapeutic use of agonist ligands specific to G2A receptor |
| 08/12/2008 | US7410799 In vivo production and delivery of erythropoietin or insulinotropin for gene therapy |
| 08/12/2008 | US7410780 IL-21 antagonists |
| 08/12/2008 | US7410767 Contacting natural killer cells expressing CD94 receptor with human leukocyte antigen (HLA) and test compound; |
| 08/12/2008 | US7410642 Assays and therapies for latent viral infection |
| 08/12/2008 | US7410641 Hybridoma and monoclonal antibodies produced; insulin-like growth factor (IGF); diagnosis, treatment, prevention of diabetes and metabolic disorders |
| 08/12/2008 | CA2398111C 4-pyridyl-and 2,4-pyrimidinyl-substituted pyrrole derivatives and their use in pharmacy |
| 08/12/2008 | CA2368574C Compositions for preventing and treating type i allergy |
| 08/12/2008 | CA2330235C Antigenic complex comprising immunostimulatory peptide, cd4, and chemokine receptor domain for hiv treatment and immune disorders |
| 08/12/2008 | CA2320224C Method for modulating macrophage activation |
| 08/12/2008 | CA2315721C Composition for treating respiratory and skin diseases, comprising at least one leukotriene antagonist and at least one antihistamine |
| 08/12/2008 | CA2239799C Murine monoclonal anti-idiotype antibody 11d10 and methods of use thereof |
| 08/12/2008 | CA2184828C Composition for inactivating irritants in fluids |
| 08/07/2008 | WO2008094942A2 Humanized antibodies against cxcr3 |
| 08/07/2008 | WO2008094222A2 Porphyrin catalysts and methods of use thereof |
| 08/07/2008 | WO2008093756A1 Biological preparation |
| 08/07/2008 | WO2008093700A1 Trehalose compound, process for production of the compound, and immuno-stimulative agent comprising the compound |
| 08/07/2008 | WO2008092996A1 Prevention of allergic sensitization |
| 08/07/2008 | WO2008092930A1 Chromene s1p1 receptor antagonist |
| 08/07/2008 | WO2008092844A1 Piperidin-acetamide derivatives for the treatment of inflammatory or allergic diseases |
| 08/07/2008 | WO2008092199A1 Thiopyrimidine-based compounds and uses thereof |
| 08/07/2008 | WO2008058098A3 Method of treating asthma, allergic rhinitis, and skin disorders |
| 08/07/2008 | WO2008036642A3 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase |
| 08/07/2008 | WO2007147019A3 Il-17 and il-23 antagonists and methods of using the same |
| 08/07/2008 | WO2007140222A3 Pyrrolopyrimidine compounds and their uses |
| 08/07/2008 | WO2007124077A3 Immunoglobulin constant region domains with enhanced stability |
| 08/07/2008 | WO2006022409A8 Hazardous substance scavenger and application apparatus and application method therefor |
| 08/07/2008 | US20080188501 retrovirus inhibor; anticarcinogenic, antidiabetic agent, immunosuppressant, autoimmune diseases; 2-{6-[3(R)-Amino-piperidin-1-yl]-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl}-4-fluoro-benzonitrile; type 2 diabetes mellitus, impaired glucose tolerance, obesity, multiple sclerosis |
| 08/07/2008 | US20080188500 e.g. N-[4-methyl-3-(9H-pyrimido[4,5-b]indol-7-yl)phenyl]-3-(trifluoromethyl)benzamide; Janus kinases inhibitor; anticarcinogenic agent; immune-related diseases, skin disorders, myeloid proliferative disorders |
| 08/07/2008 | US20080188469 Vaccination |
| 08/07/2008 | US20080188459 antiinflammatory agents; side effects rduction; less toxicity, irritation, allergic response; rheumatoid arthritis, psoriasis, asthma, Crohn's disease, ulcerative colitis, COPD ; rel-N-[(2R,10,14b)-8-cyano-1,2,3,4,10,14b-hexahydro-10-methyldibenzo[c,f]pyrido[1,2-a]azepin-2-yl]-2,2,2-trifluoroacetamide |
| 08/07/2008 | US20080188452 Macrocyclic Benzofused Pyrimidine Derivatives |
| 08/07/2008 | US20080188422 Peptides having separate domains; AIDS, cardiovascular disease, hepatitis. diabetes, cancer; side effect reduction |
| 08/07/2008 | US20080188417 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 08/07/2008 | US20080188404 Hybrid And Chimeric Polypeptides That Regulate Activation Of Complement |
| 08/07/2008 | US20080188401 Compounds |
| 08/07/2008 | US20080187994 Using f-met-leu-x peptides to modify lymphocyte response to immunoglobulin-e challenge; immunotherapy |
| 08/07/2008 | US20080187593 Administering sophorolipids; antiallergens, atopic diseases; skin disorders; antiinflammatory agents; autoimmune diseases; multiple sclerosis |
| 08/07/2008 | US20080187589 Multi-modal delivery via transmucosal and gastro-intestinal absorption of antihistamines and symptom relief |
| 08/07/2008 | US20080187575 Pyrimidine Derivatives |
| 08/07/2008 | US20080187559 Solvent extraction of lipids from cancer cells; mixture of cancer cell particles and carrier that induce immunology stimulation |
| 08/07/2008 | US20080187558 High speed dissolving dosage form; administering to mucous membranes;matric containing gelating, starch nd mannitol |
| 08/07/2008 | US20080187552 Novel vaccine composition and use of surfactants as adjuvants of immunity |
| 08/07/2008 | US20080187550 Using bacterial dnaJ chaperone protein sequences as agent to enhance immune respone; for use in treatment and prevention of arthritic inflammation |
| 08/07/2008 | US20080187539 Chemokine receptor specific monoclonal antibody for prevention and treatment of human immunodeficiency infection |
| 08/07/2008 | DE102007061631A1 Verfahren zur Herstellung von Mycophenolat-Mofetil Process for the preparation of mycophenolate mofetil |
| 08/07/2008 | DE102007004781A1 Verwendung von Guanidinoessigsäure(-Salzen) zur Herstellung eines gesundheitsfördernden Mittels The use of guanidinoacetic acid (salts) for the preparation of a beneficial agent |
| 08/07/2008 | CA2702647A1 Thiopyrimidine-based compounds and uses thereof |
| 08/07/2008 | CA2677163A1 Humanized antibodies against cxcr3 |
| 08/07/2008 | CA2676624A1 Prevention of allergic sensitization |
| 08/07/2008 | CA2675471A1 Chromene s1p1 receptor antagonist |
| 08/07/2008 | CA2675348A1 Piperidin-acetamide derivatives for the treatment of inflammatory or allergic diseases |
| 08/07/2008 | CA2659275A1 Chimeric influenza virus-like particles |
| 08/07/2008 | CA2657955A1 Chimeric virus-like particles |
| 08/07/2008 | CA2655903A1 Ilt3 binding molecules and uses therefor |
| 08/07/2008 | CA2651866A1 Sialoadhesin-related compositions and methods |
| 08/06/2008 | EP1953173A1 Secreted and transmembrane polypeptides and nucleic acids endoding the same |
| 08/06/2008 | EP1953170A1 Monosaccharide derivatives as anti-inflammatory agents |
| 08/06/2008 | EP1953162A1 Xanthin derivatives, their production and utilisation as medicine |
| 08/06/2008 | EP1953142A1 Process for the preparation of antihistaminic 4-diphenylmethyl piperidine derivatives |
| 08/06/2008 | EP1952814A1 Therapeutic agent comprising glycolipid derivative capable of inhibiting the function of nkt cell as active ingredient |
| 08/06/2008 | EP1951760A2 Human monoclonal antibody human cd134 (ox40) and methods of making and using same |
| 08/06/2008 | EP1951708A2 Piperazine derivatives useful as ccr5 antagonists |
| 08/06/2008 | EP1951703A2 Desloratadine crystalline forms mixtures having a low level of residual solvents |
| 08/06/2008 | EP1951674A1 Sulfonamide derivatives and use thereof for the modulation of metalloproteinases |
| 08/06/2008 | EP1951294A1 Immunomodulatory properties of multipotent adult progenitor cells and uses thereof |
| 08/06/2008 | EP1951287A2 Medicament for treating problems relating to fertility and pregnancy, and auto-immune diseases, and for inducing an immunological tolerance in transplant patients, and method for producing said medicament |
| 08/06/2008 | EP1951282A1 Treatment of hypersensitivity |
| 08/06/2008 | EP1951273A1 Use of lactobacillus for treatment of autoimmune diseases |
| 08/06/2008 | EP1951261A2 Compositions and methods for treating inflammatory disorders |
| 08/06/2008 | EP1951233A1 Pirfenidone/toll-like receptor (tlr) agonist compositions and methods for using them to stimulate production of granulocyte colonizing stimulating factor (g-csf) |
| 08/06/2008 | EP1585546B1 Kim-1 antagonists and use to modulate immune system |
| 08/06/2008 | EP1485088B1 Opioid receptor active 4-(3-hydroxyphenyl) or 4-(3-alkoxyphenyl)-1,2,4-triazole compounds |
| 08/06/2008 | EP1397382B1 Novel estrogen receptor ligand binding domain variants and novel ligands and pharmaceutical compositions |
| 08/06/2008 | EP1377671B1 Oncolytic adenoviral vectors |